S.H. Rosenberg
- Hematology top 10%
-
- Cancer therapeutics and mechanisms 2
- Receptor Mechanisms and Signaling 2
- Fibroblast Growth Factor Research 1
-
- Renin-Angiotensin System Studies 4
-
- Eicosanoids and Hypertension Pharmacology 2
-
- Microtubule and mitosis dynamics 2
-
- Bioactive Compounds and Antitumor Agents 1
-
- Click Chemistry and Applications 1
- Co-authors
- Steven W. ElmoreLaurie IciekMorey L. SmithPaul NimmerRyan M. FryerGlenn A. ReinhartRandy NelsonLee C. Preusser
- Cited by
- HematologyGeneticsOncology
- Journals
- European Journal of Cancer (3 papers)Clinical Chemistry (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
S.H. Rosenberg
11 papers receiving 577 citations
Peers
Comparison fields: 5 of 74
- Hematology 140
- Genetics 74
- Oncology 182
- Molecular Biology 356
- Cancer Research 60
Countries citing papers authored by S.H. Rosenberg
This map shows the geographic impact of S.H. Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.H. Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.H. Rosenberg more than expected).
Fields of papers citing papers by S.H. Rosenberg
This network shows the impact of papers produced by S.H. Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.H. Rosenberg. The network helps show where S.H. Rosenberg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S.H. Rosenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 335 | |
| 2 | 2004 | 38 | |
| 3 | 2004 | 4 | |
| 4 | A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors. | 2001 | 60 |
| 5 | 2000 | 43 | |
| 6 | 2000 | 10 | |
| 7 | 1999 | 37 | |
| 8 | 1992 | 2 | |
| 9 | 1990 | 0 | |
| 10 | 1990 | 5 | |
| 11 | Retinoblastoma. The relationship of proliferating cells to blood vessels. | 1990 | 38 |
| 12 | 1988 | 16 |
About S.H. Rosenberg
S.H. Rosenberg is a scholar working on Toxicology, Biochemistry, Cardiology and Cardiovascular Medicine, Immunology and Allergy and Nephrology, having authored 12 papers that have together received 588 indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (4 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Microtubule and mitosis dynamics (2 papers), Cancer therapeutics and mechanisms (2 papers), Receptor Mechanisms and Signaling (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), Click Chemistry and Applications (1 paper) and Fibroblast Growth Factor Research (1 paper). The work is most often cited by research in Hematology (140 citations), Genetics (74 citations), Oncology (182 citations), Molecular Biology (356 citations) and Cancer Research (60 citations). S.H. Rosenberg has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Steven W. Elmore, Laurie Iciek, Morey L. Smith, Paul Nimmer, Ryan M. Fryer, Glenn A. Reinhart, Randy Nelson, Lee C. Preusser, S. J. Morgan and Christin Tse. Their work appears in journals such as European Journal of Cancer, Clinical Chemistry, Journal of Pharmacology and Experimental Therapeutics, Cancer Chemotherapy and Pharmacology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.